Brr2 Inhibitor C9
CAS No. 2104030-82-0
Brr2 Inhibitor C9( Brr2 Inhibitor 9 )
Catalog No. M22508 CAS No. 2104030-82-0
Brr2 inhibitor C9 is an allosteric inhibitor of the spliceosomal RNA helicase Brr2. Brr2 is implicated in autosomal-dominant retinitis pigmentosa (a group of progressive retinal degenerative disorders).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 112 | In Stock |
|
| 2MG | 60 | In Stock |
|
| 5MG | 93 | In Stock |
|
| 10MG | 164 | In Stock |
|
| 25MG | 307 | In Stock |
|
| 50MG | 434 | In Stock |
|
| 100MG | 607 | In Stock |
|
| 200MG | 817 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBrr2 Inhibitor C9
-
NoteResearch use only, not for human use.
-
Brief DescriptionBrr2 inhibitor C9 is an allosteric inhibitor of the spliceosomal RNA helicase Brr2. Brr2 is implicated in autosomal-dominant retinitis pigmentosa (a group of progressive retinal degenerative disorders).
-
DescriptionBrr2 inhibitor C9 is an allosteric inhibitor of the spliceosomal RNA helicase Brr2. Brr2 is implicated in autosomal-dominant retinitis pigmentosa (a group of progressive retinal degenerative disorders).
-
In Vitro——
-
In Vivo——
-
SynonymsBrr2 Inhibitor 9
-
PathwayOthers
-
TargetOther Targets
-
Recptorspliceosomal RNA helicase Brr2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2104030-82-0
-
Formula Weight444.5
-
Molecular FormulaC24H20N4O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (112.48 mM)
-
SMILESO=C1Nc2cc(=O)n(Cc3ccccc3)cc2CN1c1cccc(OCc2cncs2)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
2,4,6-Trihydroxybenz...
2,4,6-Trihydroxybenzaldehyde is a natural product. 2,4,6-Trihydroxybenzaldehyde, a potential anti-obesity treatment.
-
UCL 2077
UCL 2077 is a subtype-selective blocker of the epilepsy-associated KCNQ channels and it also is a selective slow-afterhyperpolarization channel blocker.
-
Compound 35
Compounds 35 are superior inhibitors of Ebola (Mayinga) and Marburg (Angola) infectious viruses.Compounds 35 are superior inhibitors of Ebola (Mayinga) and Marburg (Angola) infectious viruses. Compounds 35 have shown good metabolic stability in plasma and liver microsomes (rat and human), and 32 did not inhibit CYP3A4 nor CYP2C9.
Cart
sales@molnova.com